where is the interest

I am a little concerned at the continued lack of intrest and the recent pull back on the BUY demand.

Here we have a drug which everyone says performs better than best current care, Was marketed for 2nd line therapy where is definately proven so market potential should at least meet and exceed initial valuations, phase 3 complted and risk profile reduced yet very little interets at the speculative level

Partnership announcement if as per other posts here the drug is a keepercould occur anyday yet the speculative interest appears to be dissipating if anything